肺癌的一级和二级预防：烟草治疗。

Primary and Secondary Prevention of Lung Cancer: Tobacco Treatment.

机构信息

The Pulmonary Center, Boston University Medical Center, Boston University, 72 East Concord Street R304, Boston, MA 02118, USA.

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, 1830 East Monument Street, Room 549, Baltimore, MD 21287, USA.

出版信息

Clin Chest Med. 2020 Mar;41(1):39-51. doi: 10.1016/j.ccm.2019.10.002.

DOI:10.1016/j.ccm.2019.10.002

PMID:32008628

Abstract

Tobacco dependence is the most consequential target to reduce the burden of lung cancer worldwide. Quitting after a cancer diagnosis can improve cancer prognosis, overall health, and quality of life. Several oncology professional organizations have issued guidelines stressing the importance of tobacco treatment for patients with cancer. Providing tobacco treatment in the context of lung cancer screening is another opportunity to further reduce death from lung cancer. In this review, the authors describe the current state of tobacco dependence treatment focusing on new paradigms and approaches and their particular relevance for persons at risk or on treatment for lung cancer.

摘要

烟草依赖是降低全球肺癌负担的最重要目标。癌症诊断后戒烟可以改善癌症预后、整体健康状况和生活质量。一些肿瘤学专业组织发布了指南，强调了为癌症患者提供烟草治疗的重要性。在肺癌筛查的背景下提供烟草治疗是进一步降低肺癌死亡率的另一个机会。在这篇综述中，作者描述了烟草依赖治疗的现状，重点介绍了新的模式和方法及其对肺癌风险人群或治疗人群的特殊相关性。